Oligodeoxyribonucleotides of 4000-10000 Dalton for treating tumors

Details for Australian Patent Application No. 2006222045 (hide)

Owner Gentium SpA

Inventors Ferro, Laura Iris; Eissner, Gunther; Iacobelli, Massimo

Agent Griffith Hack

Pub. Number AU-B-2006222045

PCT Pub. Number WO2006/094917

Priority 60/731,404 28.10.05 US; MI2005A000336 03.03.05 IT

Filing date 27 February 2006

Wipo publication date 14 September 2006

Acceptance publication date 20 October 2011

International Classifications

A61K 31/711 (2006.01) - Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

30 August 2007 PCT application entered the National Phase

  PCT publication WO2006/094917 Priority application(s): WO2006/094917

20 October 2011 Application Accepted

  Published as AU-B-2006222045

16 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006222048-Process for the preparation of 1-aminopiperidine derivatives

2006222044-Defibrotide and/or oligodeoxyribonucleotides for treating angiogenesis-dependent tumors